Search

Agnieszka Boesen

Examiner (ID: 10144, Phone: (571)272-8035 , Office: P/1648 )

Most Active Art Unit
1648
Art Unit(s)
1671, 1672, 1648
Total Applications
1050
Issued Applications
614
Pending Applications
117
Abandoned Applications
353

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7323456 [patent_doc_number] => 20040137431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Target sequences for the detection of the west nile virus' [patent_app_type] => new [patent_app_number] => 10/700118 [patent_app_country] => US [patent_app_date] => 2003-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 3105 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20040137431.pdf [firstpage_image] =>[orig_patent_app_number] => 10700118 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/700118
Target sequences for the detection of the west nile virus Nov 2, 2003 Abandoned
Array ( [id] => 5776345 [patent_doc_number] => 20060104985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Dengue virus infection inhibitor' [patent_app_type] => utility [patent_app_number] => 10/532211 [patent_app_country] => US [patent_app_date] => 2003-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9688 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20060104985.pdf [firstpage_image] =>[orig_patent_app_number] => 10532211 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/532211
Dengue virus infection inhibitor Oct 21, 2003 Abandoned
Array ( [id] => 7280393 [patent_doc_number] => 20040062770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Modulators of fgl2 prothrombinase' [patent_app_type] => new [patent_app_number] => 10/688962 [patent_app_country] => US [patent_app_date] => 2003-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13035 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20040062770.pdf [firstpage_image] =>[orig_patent_app_number] => 10688962 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/688962
Modulators of fgl2 prothrombinase Oct 20, 2003 Abandoned
Array ( [id] => 5747805 [patent_doc_number] => 20060110736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Hiv vaccine formulations' [patent_app_type] => utility [patent_app_number] => 10/530543 [patent_app_country] => US [patent_app_date] => 2003-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22569 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20060110736.pdf [firstpage_image] =>[orig_patent_app_number] => 10530543 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/530543
Hiv vaccine formulations Oct 6, 2003 Abandoned
Array ( [id] => 7304355 [patent_doc_number] => 20040115752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Method for testing samples containing prion protein for the possible presence of the prpsc form' [patent_app_type] => new [patent_app_number] => 10/474107 [patent_app_country] => US [patent_app_date] => 2003-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2074 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115752.pdf [firstpage_image] =>[orig_patent_app_number] => 10474107 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/474107
Method for testing samples containing prion protein for the possible presence of the prpsc form Oct 6, 2003 Abandoned
Array ( [id] => 7280719 [patent_doc_number] => 20040063096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Oligonucleotides and method for characterizing and detecting genogroup II type small round structured virus' [patent_app_type] => new [patent_app_number] => 10/678124 [patent_app_country] => US [patent_app_date] => 2003-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7256 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063096.pdf [firstpage_image] =>[orig_patent_app_number] => 10678124 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/678124
Oligonucleotides and method for characterizing and detecting genogroup II type small round structured virus Oct 5, 2003 Abandoned
Array ( [id] => 7208985 [patent_doc_number] => 20040087774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'TRAF inhibitors' [patent_app_type] => new [patent_app_number] => 10/679014 [patent_app_country] => US [patent_app_date] => 2003-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13570 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087774.pdf [firstpage_image] =>[orig_patent_app_number] => 10679014 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/679014
TRAF inhibitors Oct 2, 2003 Abandoned
Array ( [id] => 7261514 [patent_doc_number] => 20040241191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Recombinant vaccine against West Nile virus' [patent_app_type] => new [patent_app_number] => 10/676502 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14221 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241191.pdf [firstpage_image] =>[orig_patent_app_number] => 10676502 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/676502
Recombinant vaccine against West Nile virus Sep 29, 2003 Abandoned
Array ( [id] => 7117301 [patent_doc_number] => 20050070602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Method of modulating immune response by administration of immuno-activation agent' [patent_app_type] => utility [patent_app_number] => 10/673426 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7670 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20050070602.pdf [firstpage_image] =>[orig_patent_app_number] => 10673426 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/673426
Method of modulating immune response by administration of immuno-activation agent Sep 29, 2003 Abandoned
Array ( [id] => 7349423 [patent_doc_number] => 20040047882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Adjuvant for vaccines' [patent_app_type] => new [patent_app_number] => 10/221941 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2799 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20040047882.pdf [firstpage_image] =>[orig_patent_app_number] => 10221941 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/221941
Adjuvant for vaccines Sep 28, 2003 Abandoned
Array ( [id] => 6977401 [patent_doc_number] => 20050287117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Vaccine enhancing the protective immunity to hepatitis c virus using plasmid dna and recombinant adenovirus' [patent_app_type] => utility [patent_app_number] => 10/528644 [patent_app_country] => US [patent_app_date] => 2003-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 20219 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287117.pdf [firstpage_image] =>[orig_patent_app_number] => 10528644 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/528644
Vaccine enhancing the protective immunity to hepatitis c virus using plasmid DNA and recombinant adenovirus Sep 23, 2003 Issued
Array ( [id] => 292483 [patent_doc_number] => 07544775 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-09 [patent_title] => 'Systems for expressing toxic proteins, vectors and method of producing toxic proteins' [patent_app_type] => utility [patent_app_number] => 10/528344 [patent_app_country] => US [patent_app_date] => 2003-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 8 [patent_no_of_words] => 9805 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/544/07544775.pdf [firstpage_image] =>[orig_patent_app_number] => 10528344 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/528344
Systems for expressing toxic proteins, vectors and method of producing toxic proteins Sep 18, 2003 Issued
Array ( [id] => 7325052 [patent_doc_number] => 20040138119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis' [patent_app_type] => new [patent_app_number] => 10/665975 [patent_app_country] => US [patent_app_date] => 2003-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22969 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138119.pdf [firstpage_image] =>[orig_patent_app_number] => 10665975 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/665975
Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis Sep 17, 2003 Abandoned
Array ( [id] => 4547798 [patent_doc_number] => 07820181 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens' [patent_app_type] => utility [patent_app_number] => 10/667141 [patent_app_country] => US [patent_app_date] => 2003-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 60957 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820181.pdf [firstpage_image] =>[orig_patent_app_number] => 10667141 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/667141
Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens Sep 17, 2003 Issued
Array ( [id] => 7230706 [patent_doc_number] => 20050079171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Pseudomonas exotoxin A-like chimeric immunogens for eliciting a secretory IgA-mediated immune response' [patent_app_type] => utility [patent_app_number] => 10/659036 [patent_app_country] => US [patent_app_date] => 2003-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 25139 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20050079171.pdf [firstpage_image] =>[orig_patent_app_number] => 10659036 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/659036
Pseudomonas exotoxin A-like chimeric immunogens for eliciting a secretory IgA-mediated immune response Sep 8, 2003 Abandoned
Array ( [id] => 7460333 [patent_doc_number] => 20040052812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Heat shock protein-based antiviral vaccines' [patent_app_type] => new [patent_app_number] => 10/258146 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11876 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20040052812.pdf [firstpage_image] =>[orig_patent_app_number] => 10258146 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/258146
Heat shock protein-based antiviral vaccines Sep 4, 2003 Abandoned
Array ( [id] => 448261 [patent_doc_number] => 07250251 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-31 [patent_title] => 'Virion-based fusion assay' [patent_app_type] => utility [patent_app_number] => 10/656803 [patent_app_country] => US [patent_app_date] => 2003-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 15859 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/250/07250251.pdf [firstpage_image] =>[orig_patent_app_number] => 10656803 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/656803
Virion-based fusion assay Sep 3, 2003 Issued
Array ( [id] => 7229198 [patent_doc_number] => 20040073259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Treatment of patients infected by disease causing organisms or biological warfare agents using hyperthermia' [patent_app_type] => new [patent_app_number] => 10/649544 [patent_app_country] => US [patent_app_date] => 2003-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11046 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20040073259.pdf [firstpage_image] =>[orig_patent_app_number] => 10649544 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/649544
Treatment of patients infected by disease causing organisms or biological warfare agents using hyperthermia Aug 25, 2003 Abandoned
Array ( [id] => 5726876 [patent_doc_number] => 20060057636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins' [patent_app_type] => utility [patent_app_number] => 10/525533 [patent_app_country] => US [patent_app_date] => 2003-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18634 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057636.pdf [firstpage_image] =>[orig_patent_app_number] => 10525533 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/525533
Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins Aug 24, 2003 Abandoned
Array ( [id] => 7246456 [patent_doc_number] => 20050272029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Hepatitis c viral-like particle purification' [patent_app_type] => utility [patent_app_number] => 10/524443 [patent_app_country] => US [patent_app_date] => 2003-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 18814 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272029.pdf [firstpage_image] =>[orig_patent_app_number] => 10524443 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/524443
Hepatitis c viral-like particle purification Aug 17, 2003 Abandoned
Menu